Quantoom Biosciences SA
Quantoom Biosciences develops integrated technologies and services to support design, production and formulation of mRNA and self-amplifying RNA (saRNA) vaccines and therapeutics. Its portfolio includes a bioinformatics RNA design platform, enzymatic linear DNA amplification services, formulation chemistry for lipid nanoparticle delivery, and automated, scalable mRNA production systems with single-step purification and process-intensification approaches. The company publishes case studies, white papers and webinars and collaborates with academic and industry partners on pre-clinical and scale-up projects.
Industries
N/A
Products
All-in-one mRNA production kit (research)
A compact kit intended to support rapid and scalable mRNA production workflows for research purposes, including reagents and disposables.
Automated mRNA production system for pre-clinical development
Bench-to-pilot automated production equipment designed for pre-clinical and drug-discovery workflows, implementing an optimized IVT and a single purification step.
Automated mRNA production system for clinical and commercial manufacturing
Larger-scale automated production system that scales by parallel reaction cavities and is intended to support clinical trials and commercial manufacturing.
All-in-one mRNA production kit (research)
A compact kit intended to support rapid and scalable mRNA production workflows for research purposes, including reagents and disposables.
Automated mRNA production system for pre-clinical development
Bench-to-pilot automated production equipment designed for pre-clinical and drug-discovery workflows, implementing an optimized IVT and a single purification step.
Automated mRNA production system for clinical and commercial manufacturing
Larger-scale automated production system that scales by parallel reaction cavities and is intended to support clinical trials and commercial manufacturing.
Services
Bioinformatics RNA design service
Platform-driven design of optimised mRNA constructs from amino-acid or antigen sequences for research and development programs.
Linear DNA amplification service for mRNA synthesis
Enzymatic amplification of linear DNA templates (2–20 kb) at scales suitable for research through production, available in research and high-quality grades for downstream use.
Formulation and LNP development services
Formulation chemistry and process development for LNP-based delivery of (sa)mRNA for vaccines and therapeutics.
Bioinformatics RNA design service
Platform-driven design of optimised mRNA constructs from amino-acid or antigen sequences for research and development programs.
Linear DNA amplification service for mRNA synthesis
Enzymatic amplification of linear DNA templates (2–20 kb) at scales suitable for research through production, available in research and high-quality grades for downstream use.
Formulation and LNP development services
Formulation chemistry and process development for LNP-based delivery of (sa)mRNA for vaccines and therapeutics.
Expertise Areas
- mRNA and self-amplifying RNA (saRNA) process development
- Bioinformatics-driven RNA design
- Lipid nanoparticle (LNP) formulation and delivery chemistry
- Automated and scalable mRNA manufacturing
Key Technologies
- mRNA and self-amplifying RNA (saRNA)
- In vitro transcription (IVT)
- Co-transcriptional mRNA capping
- Silica/magnetic-bead RNA capture purification